Table 8 Parameters of functional response of M4_G15 fusion protein to muscarinic agonists.
pEC50 | E’MAX | pKA | τ | |
|---|---|---|---|---|
[35S]GTPγS binding, EMAX = 6.85 | ||||
Arecoline | 6.98 ± 0.03 | 4.2 ± 0.2 | 6.6 ± 0.1 | 1.60 ± 0.12 |
Carbachol | 6.94 ± 0.03 | 4.3 ± 0.2 | 6.5 ± 0.1 | 1.74 ± 0.13 |
Furmethide | 6.58 ± 0.03 | 4.4 ± 0.2 | 6.1 ± 0.1 | 1.77 ± 0.13 |
Iperoxo | 7.88 ± 0.02 | 5.0 ± 0.3 | 7.3 ± 0.1 | 2.70 ± 0.22 |
McN-A-343 | 6.86 ± 0.03 | 4.0 ± 0.2 | 6.5 ± 0.1 | 1.43 ± 0.12 |
NDMC | 7.01 ± 0.03 | 3.9 ± 0.2 | 6.6 ± 0.1 | 1.32 ± 0.11 |
Oxotremorine | 7.77 ± 0.02 | 4.4 ± 0.2 | 7.3 ± 0.1 | 1.84 ± 0.13 |
Pilocarpine | 6.78 ± 0.03 | 3.0 ± 0.2 | 6.5 ± 0.1 | 0.80 ± 0.06 |
Xanomeline | 8.50 ± 0.02 | 4.6 ± 0.2 | 8.0 ± 0.1 | 2.06 ± 0.16 |
IPX level, EMAX = 4.18 | ||||
Arecoline | 7.10 ± 0.02 | 2.9 ± 0.1 | 6.6 ± 0.1 | 2.37 ± 0.22 |
Carbachol | 7.02 ± 0.03 | 3.0 ± 0.2 | 6.5 ± 0.1 | 2.45 ± 0.23 |
Furmethide | 6.67 ± 0.03 | 3.0 ± 0.2 | 6.1 ± 0.1 | 2.57 ± 0.25 |
Iperoxo | 7.97 ± 0.02 | 3.3 ± 0.2 | 7.3 ± 0.1 | 3.9 ± 0.4 |
McN-A-343 | 6.92 ± 0.03 | 2.8 ± 0.1 | 6.5 ± 0.1 | 1.96 ± 0.18 |
NDMC | 7.10 ± 0.03 | 2.7 ± 0.1 | 6.7 ± 0.1 | 1.79 ± 0.16 |
Oxotremorine | 7.82 ± 0.02 | 3.0 ± 0.2 | 7.3 ± 0.1 | 2.48 ± 0.24 |
Pilocarpine | 6.85 ± 0.02 | 2.2 ± 0.1 | 6.5 ± 0.1 | 1.08 ± 0.09 |
Xanomeline | 8.62 ± 0.02 | 3.1 ± 0.2 | 8.0 ± 0.1 | 2.77 ± 0.28 |
Intracellular Ca2+ level, EMAX = 1.861 | ||||
Arecoline | 8.32 ± 0.02 | 1.828 ± 0.003 | 6.6 ± 0.1 | 57 ± 10 |
Carbachol | 8.22 ± 0.03 | 1.829 ± 0.003 | 6.4 ± 0.1 | 59 ± 10 |
Furmethide | 7.93 ± 0.03 | 1.830 ± 0.003 | 6.1 ± 0.1 | 61 ± 11 |
Iperoxo | 9.27 ± 0.02 | 1.839 ± 0.003 | 7.3 ± 0.1 | 87 ± 29 |
McN-A-343 | 8.08 ± 0.03 | 1.820 ± 0.003 | 6.4 ± 0.1 | 45 ± 5 |
NDMC | 8.24 ± 0.03 | 1.816 ± 0.003 | 6.6 ± 0.1 | 41 ± 6 |
Oxotremorine | 9.05 ± 0.02 | 1.831 ± 0.003 | 7.2 ± 0.1 | 63 ± 11 |
Pilocarpine | 8.00 ± 0.02 | 1.791 ± 0.003 | 6.6 ± 0.1 | 26 ± 4 |
Xanomeline | 9.93 ± 0.02 | 1.834 ± 0.003 | 8.1 ± 0.1 | 71 ± 14 |